SC
MRNA icon

SRB Corp’s Moderna MRNA Stock Holding History

SRB Corp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,216
Closed -$340K – 118
2023
Q1 		$340K Sell
2,216
-196
-8% -$32.3K 0.02% 97
2022
Q4 		$433K Buy
+2,412
New +$394K 0.03% 75
2022
Q3 		– Sell
-11,723
Closed -$1.68M – 107
2022
Q2 		$1.68M Buy
11,723
+5,799
+98% +$829K 0.11% 15
2022
Q1 		$1.02M Hold
5,924
– – 0.06% 112
2021
Q4 		$1.5M Buy
+5,924
New +$1.73M 0.08% 27

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SRB Corp's MRNA Position: Q2 2023 in Review

SRB Corp sold out of Moderna (MRNA) in Q2 2023, closing a stake of 2,216 shares — an estimated $340K sold.

SRB Corp first reported a position in MRNA in Q4 2021 and held it in 5 quarters. The position peaked at $1.68M in Q2 2022. 966 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • SRB Corp reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • SRB Corp sold 2,216 Moderna shares in Q2 2023, an estimated $340K.
  • SRB Corp first reported a position in Moderna in Q4 2021 and held it in 5 quarters.
  • SRB Corp's Moderna position peaked at $1.68M in Q2 2022.
  • 966 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on SRB Corp's 13F filing for Q2 2023, filed 14 Aug 2023.